Seishi Ogawa
Kyoto, 6068501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 733 publications
Long-term remission with venetoclax plus azacitidine in acute myeloid leukemia with negative conversion of FLT3 companion diagnostic testing at relapse
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 03, 2026
Personalized reference genome-based pipeline reveals comprehensive haplotype-resolved views of cancer genomes.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
Journal: American journal of hematology
Published: June 25, 2026
Clonal hematopoiesis related to ionizing radiation in atomic bomb survivors.
Journal: Leukemia
Published: May 12, 2026
Late acquisition of BCR::ABL1 during clonal evolution of SAMD9-associated MDS with phenotypic shift from AML to B-ALL.
Journal: International journal of hematology
Published: April 21, 2026
Independent clonal evolution in primary pigmented nodular adrenocortical disease: a single-patient multi-omics study.
Journal: European journal of endocrinology
Published: April 12, 2026
Trisomy 8 clonal expansion during disease progression and azacitidine resistance in VEXAS syndrome: a case report.
Journal: Frontiers in immunology
Published: March 28, 2026
Search for the Decay B^{+}→K^{+}τ^{+}τ^{-} Using Data from the Belle and Belle II Experiments.
Journal: Physical review letters
Published: March 27, 2026
Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.
Journal: British journal of haematology
Published: March 25, 2026
Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes.
Journal: Blood cancer journal
Published: March 24, 2026
Last Updated: 09/26/2026